Skip to main content

News

head uk2

Chitosan in Tissue Engineering Applications

Dr. Thomas Freier

Tissue engineering is a rapidly growing interdisciplinary field of research focused on the development of vital autologous tissue through the use of a combination of biomaterials, cells, and bioactive molecules, for the purposes of repairing damaged or diseased tissue and organs. The future tissue engineering market potential has been estimated at 70 billion Euro. Due to its biocompatibility and biodegradability, together with its specific interactions with components of the extracellular matrix and growth factors, chitosan has emerged as exceptionally promising material for various tissue engineering applications, including skin, nerve, bone, and cartilage repair applications.

Modifying the degree of acetylation (DA) of chitosan provides a powerful means for controlling biodegradation and biocompatibility in tissue engineering applications. Prolonged degradation times and enhanced cell adhesion can be achieved using chitosan with a DA close to 0%. Slightly higher DAs, up to about 20%, allow for faster degradation and comparatively good cell adhesion and differentiation. Fastest degradation can be achieved with chitosan having intermediate DAs, but at the cost of limited cell compatibility (Figs.).

HMC medical chitosan 2008 004 HMC medical chitosan 2008 033

 

 

 

 

 

 

 

 

Despite the high potential of chitosan, there are still limitations for its broad use in tissue engineering. For example, porous chitosan matrices which allow for cell ingrowth and tissue regeneration have low mechanical strength under physiological conditions. As an alternative textile based scaffolds, made from chitosan fibres, may be able to overcome the insufficient strength. Another issue to be solved is the natural origin of the biopolymer that requires well-selected sources of raw material in sufficient quantities together with a specific purification methodology leading to medical grade biomaterials of defined and reproducible properties.

HMC medical chitosan 2008 055

HMC medical chitosan 2008 044

 

 

 

chitosan, tissue regeneration, scaffold, tissue engineering

Congress and fairs

Meet us in person 2024:

  • 14th PBP World Meeting/ Research Pharm, Vienna, Austria, 18.-21.03.2024
  • EPNOE Workshop on Analytics of Polysaccharides, ETH Zürich, Zürich, Switzerland, 25.-26.06.2024
  • CPHI, Milan, Italy, 08.-10.10.2024
  • MEDICA 2024, Düsseldorf, Germany, 11.-14.11.2024

To arrange an appointment please contact Katja Richter via This email address is being protected from spambots. You need JavaScript enabled to view it.

Contact

  • Heppe Medical Chitosan GmbH
    Heinrich-Damerow-Strasse 1
    06120 Halle (Saale)
    Germany
  • Tel.: +49 (0) 345 27 996 300
    Fax: +49 (0) 345 27 996 378
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.